Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Temidayo Fadelu, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Butaro Cancer Center of Excellence
Butaro, RN8, Rwanda
Temidayo Fadelu, MD
- Boston Children'S Hospital
Boston, Massachusetts, United States
Temidayo Fadelu, MD - Brigham and Women'S Hospital
Boston, Massachusetts, United States
Temidayo Fadelu, MD - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Temidayo Fadelu, MD
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2026
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2028
- Last update posted
- 20 May 2026
- Registered enrollment
- 224
- Registry id
- NCT07562399
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.